Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Julianna Bronk Image

      Julianna Bronk, MD, PhD

      Department of Thoracic Radiation Oncology, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, UT

      Dual/Joint/Adjunct Appointment

      Assistant Professor, Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, UT

      Education & Training

      Degree-Granting Education

      2018Baylor College of Medicine, Houston, Texas, US, Doctor of Medicine, MD
      2014MD Anderson UT Health Graduate School for Biomedical Science, Houston, Texas, US, Biomedical Science, PhD
      2008Massachusetts Institute of Technology, Cambridge, Massachusetts, US, Chemical Engineering, BS

      Postgraduate Training

      2019-2023Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2018-2019Clinical Residency, Internal Medicine, University of Texas McGovern Medical School, Houston, Texas

      Licenses & Certifications

      2023Texas Medical Board
      2021AHA Pediatric Advanced Life Support
      2018AHA Advanced Cardiac Life Support

      Experience & Service

      Administrative Appointments/Responsibilities

      Operations Liaison, Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present

      Other Professional Positions

      Executive Committee Member, MD Anderson Brain Tumor Center, Houston, TX, 2022 - 2023

      Graduate Student Representative, MD Anderson UT Health Graduate School Academic Standards Committee, Houston, TX, 2012 - 2013

      Intramural Institutional Committee Activities

      Committee Member, MD Anderson Medical Records Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Editorial Activities

      Invited guest editor, Frontiers in Oncology, 2022 - Present

      Editorial board member, Advances Radiotherapy & Nuclear Medicine, 2022 - Present

      Honors & Awards

      2024 - PresentBest Oral Presentation, Flash Radiotherapy & Particle Therapy
      2022Annual Meeting Travel Grant Award- Biology section, ASTRO
      2022Caroline Ross Distinguished Fellow Award, MD Anderson Brain Tumor Center
      2022Travel Grant Award, American Radium Society
      2022Shark Tank Competition Finalist, MD Anderson Brain Tumor Center
      2021Dr. Mary Fletcher Memorial Award for Compassionate Patient Care, University of Texas MD Anderson Cancer Center
      2021Invited Scholar, STARS21 program, University of Toronto, Princess Margaret Hospital
      2017Alpha Omega Alpha Honor Society, Baylor College of Medicine
      2014Kilson Education Foundation Scholarship, Baylor College of Medicine
      2013Investing in Student Futures Endowed Scholarship, University of Texas MD Anderson Cancer Center
      2012Rosalie B. Hite Endowed Graduate Fellowship, University of Texas MD Anderson Cancer Center
      20111st place, Poster Competition, Center for Transport Oncophysics Conference
      2010Graduate Fellowship, Center for Medical System Innovation, University of Tokyo
      2010Travel Award, AC Camargo Translational Science Conference, San Paulo, Brazil, Hospital AC Camargo

      Professional Memberships

      Radiological Society of North America

      2019 - Present

      American Society of Clinical Oncology (ASCO)

      2019 - Present

      American College of Radiation Oncology (ACRO)

      2019 - Present

      American Society of Radiation Oncology (ASTRO)

      2019 - Present

      Alpha Omega Alpha (AOA) Honor Society

      2018 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2024. American Society for Radiation Oncology. Invited. Washington, D.C, District of Columbia, US.
      2. 2022. Pediatric Radiation Oncology Society, US.
      3. 2022. American Radium Society, US.
      4. 2022. American Radium Society, US.
      5. 2021. American Society for Radiation Oncology, US.
      6. 2021. American Radium Society, US.
      7. 2020. American Society for Radiation Oncology. Poster Presenter, US.
      8. 2020. Radiation Research Society, US.
      9. 2019. American Society for Radiation Oncology, US.
      10. 2018. American Roentgen Ray Society, US.
      11. 2016. Society for Neuro-Oncology, US.
      12. 2012. The Methodist Research Institute, US.
      13. 2011. AACR, US.

      International Presentations

      1. 2022. American Society for Radiation Oncology, DE.
      2. 2017. European Society of Neuroradiology, SE.
      3. 2010. Hospital AC Camargo, BR.
      Read More
      Less

      Grant & Contract Support

      Date: 2021 - 2023
      Title:Expanding the therapeutic window for radiation in brain tumors with ultra-high dose rate proton FLASH radiotherapy
      Funding Source:Radiological Society of North America (RSNA)
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Lin, R, Chen, M, Zhang, X, Xu, T, Xu, T, Maguire, RC, Corrigan, KL, Koutroumpakis, E, Chang, JY, Lin, SH, Chen, A, Nguyen, Q, Gandhi, S, Ning, M, Bronk, JK, Chun, SG, Ajdari, A, Niedzielski, JS, Yang, J, Chen, X, Pan, T, Meng, QH, Tsao, A, Deswal, A, Mohan, R, Liao, Z. Bayesian Learning to Reduce Cardiac Risk of Patients With Locally Advanced Non-Small Cell Lung Cancer Based on Personalized Radiation Therapy Prescription. International Journal of Radiation Oncology Biology Physics 125(3):949-958, 2026. e-Pub 2026. PMID: 41365476.
      2. Zhang, B, Shah, K, Parma, M, Wang, K, Singhi, EK, Lewis, WE, Rivera, MJ, Altan, M, Pozadzides, JV, Le, X, Vokes, N, Fossella, FV, O'Brien, BJ, Wang, C, Tom, MC, Beckham, TH, Swanson, T, Bronk, JK, Lin, SH, Vega, MF, Jacome, J, Halliday, A, Vailati Negrao, M, Zhang, J, Gibbons, DL, Heymach, JV, Byers, LA, Gay, CM. Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series. Journal of Thoracic Oncology 20(8):1131-1138, 2025. e-Pub 2025. PMID: 40126456.
      3. Pasqualini, R, Markosian, C, Staquicini, DI, Dobroff, AS, Dodero-Rojas, E, Whitford, PC, Barbu, EM, Bronk, JK, Cardó-Vila, M, Christianson, DR, Dias-Neto, E, Driessen, WH, Guzman-Rojas, L, Marchiò, S, Nunes, D, de Oliveira, FS, Ozawa, MG, Proneth, B, Rangel, R, Smith, TL, Souza, GR, Staquicini, FI, Tang, FH, Baze, W, Setubal, JC, Burns, JW, Dubick, MA, Gelovani, J, Batchinsky, AI, Mogford, JE, Wade, CE, Holcomb, JB, Burley, SK, Onuchic, JN, Arap, W. Conformational ligand-directed targeting of calcium-dependent receptors in acute trauma. Med 6(7), 2025. e-Pub 2025. PMID: 40609540.
      4. Odwuor, A, Lee, PP, Chang, JY, Gandhi, S, Liao, Z, Lin, SH, Chen, A, Nguyen, Q, O'Reilly, M, Chun, SG, Bronk, JK, Qian, DC, Ning, M. Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. Clinical Lung Cancer 26(5):384-392, 2025. e-Pub 2025. PMID: 40318943.
      5. Guan, F, Jiang, D, Wang, X, Yang, M, Iga, K, Li, Y, Bronk, LF, Bronk, JK, Wang, L, Guo, Y, Sahoo, N, Grosshans, DR, Koong, A, Zhu, XR, Mohan, R. Mimicking large spot-scanning radiation fields for proton FLASH preclinical studies with a robotic motion platform. Precision Radiation Oncology 8(4):168-181, 2024. e-Pub 2024. PMID: 40337456.
      6. Bronk JK, Augustyn A, Mohamed ASR, David Fuller C, Garden AS, Moreno AC, Lee A, Morrison WH, Phan J, Reddy JP, Rosenthal DI, Spiotto MT, Frank SJ, Dadu R, Busaidy N, Zafereo M, Wang JR, Maniakas A, Ferrarotto R, Iyer PC, Cabanillas ME, Brandon Gunn G. Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer. Radiother Oncol 202:110602, 2024. e-Pub 2024. PMID: 39489425.
      7. Ning, M, Odwuor, A, Chang, JY, Gandhi, S, Liao, Z, Lin, SH, Chen, A, Welsh, J, Nguyen, Q, O'Reilly, M, Chun, SG, Bronk, JK, Qian, DC, Lee, PP. Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers 16(21), 2024. e-Pub 2024. PMID: 39518028.
      8. Ning MS, Odwuor A, Chang JY, Gandhi S, Liao Z, Lin SH, Chen A, Welsh JW, Nguyen Q, O’Reilly MS, Chun SG, Bronk J, Qian D, Lee P. Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers, 2024. e-Pub 2024.
      9. Fada G, Dadi J, Bronk JK. Mimicking large spot-scanning radiation fields for proton FLASH preclinical studies with a robotic motion platform. Precision Radiation Oncology, 2024. e-Pub 2024.
      10. Bronk, JK, McAleer, MF, McGovern, SL, Lassen-Ramshad, Y, Safwat, AA, Daw Bitar, N, Rainusso, N, Mahajan, A, Grosshans, DR, Paulino, AC. Comprehensive radiotherapy for pediatric Ewing Sarcoma. Radiotherapy and Oncology 195, 2024. e-Pub 2024. PMID: 38583721.
      11. Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy, 2023. e-Pub 2023. PMID: 38129211.
      12. Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41(11):1945-1962.e11, 2023. e-Pub 2023. PMID: 37863066.
      13. Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
      14. Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
      15. Bronk JK, Kapadia C, Wu X, Chapman BV, Wang R, Karpinets TV, Song X, Futreal AM, Zhang J, Klopp AH, Colbert LE. Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy. PLoS One 17(10):e0274457, 2022. e-Pub 2022. PMID: 36201462.
      16. Bronk JK, Hou P, Amsbaugh MJ, Khatua S, Mahajan A, Ketonen L, McGovern SL. Sequential Diffusion Tensor Imaging and Magnetic Resonance Spectroscopy in Patients Undergoing Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma. Adv Radiat Oncol 7(2):100847, 2022. e-Pub 2022. PMID: 35071836.
      17. Bronk JK, Amer A, Khose S, Flint D, Adair A, Yepes P, Grosshans D, Johnson J, Chung C. Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness. Adv Radiat Oncol 7(6):101044, 2022. e-Pub 2022. PMID: 36420203.
      18. Bronk JK, Guha-Thakurta N, Allen PK, Mahajan A, Grosshans DR, McGovern SL. Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. Clin Transl Radiat Oncol 9:30-34, 2018. e-Pub 2018. PMID: 29594248.
      19. Cardó-Vila M, Marchiò S, Sato M, Staquicini FI, Smith TL, Bronk JK, Yin G, Zurita AJ, Sun M, Behrens C, Sidman RL, Lee JJ, Hong WK, Wistuba II, Arap W, Pasqualini R. Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity. Am J Pathol 186(8):2162-2170, 2016. e-Pub 2016. PMID: 27317903.
      20. Nunes DN, Dias-Neto E, Cardó-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, Marchiò S, Pereira CA, Passetti F, Calin GA, Sidman RL, Arap W, Pasqualini R. Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch. Proc Natl Acad Sci U S A 112(12):3770-5, 2015. e-Pub 2015. PMID: 25775553.
      21. Staquicini FI, Qian MD, Salameh A, Dobroff AS, Edwards JK, Cimino DF, Moeller BJ, Kelly P, Nunez MI, Tang X, Liu DD, Lee JJ, Hong WK, Ferrara F, Bradbury AR, Lobb RR, Edelman MJ, Sidman RL, Wistuba II, Arap W, Pasqualini R. Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. J Biol Chem 290(12):7345-59, 2015. e-Pub 2015. PMID: 25623065.
      22. Bronk JK, Russell BH, Rivera JJ, Pasqualini R, Arap W, Höök M, Barbu EM. A multifunctional streptococcal collagen-mimetic protein coating prevents bacterial adhesion and promotes osteoid formation on titanium. Acta Biomater 10(7):3354-62, 2014. e-Pub 2014. PMID: 24732634.
      23. Guzman-Rojas L, Rangel R, Salameh A, Edwards JK, Dondossola E, Kim YG, Saghatelian A, Giordano RJ, Kolonin MG, Staquicini FI, Koivunen E, Sidman RL, Arap W, Pasqualini R. Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment. Proc Natl Acad Sci U S A 109(5):1637-42, 2012. e-Pub 2012. PMID: 22307623.
      24. Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, Tu SM, Botz GH, Wallace MJ, O'Connell DJ, Krajewski S, Gershenwald JE, Molldrem JJ, Flamm AL, Koivunen E, Pentz RD, Dias-Neto E, Setubal JC, Cahill DJ, Troncoso P, Do KA, Logothetis CJ, Sidman RL, Pasqualini R, Arap W. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A 108(46):18637-42, 2011. e-Pub 2011. PMID: 22049339.
      25. Driessen WH, Bronk LF, Edwards JK, Proneth B, Souza GR, Decuzzi P, Pasqualini R, Arap W. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection. Adv Genet 69:115-33, 2010. e-Pub 2010. PMID: 20807605.
      26. Giordano RJ, Edwards JK, Tuder RM, Arap W, Pasqualini R. Combinatorial ligand-directed lung targeting. Proc Am Thorac Soc 6(5):411-5, 2009. e-Pub 2009. PMID: 19687212.

      Review Articles

      1. Edwards JK, Pasqualini R, Arap W, Calin GA. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 3(3):271-9, 2010. e-Pub 2010. PMID: 20560048.

      Editorials

      1. Guan, F, Zhao, L, Bronk, JK, Maletić-Savatić, M, Grosshans, DR, Carlson, DJ. Editorial. Frontiers in Oncology 13, 2023. PMID: 38234403.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 24, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top